Barclays upgraded shares of Relx (NYSE:RELX – Free Report) from an equal weight rating to an overweight rating in a research note published on Friday, Marketbeat.com reports.
Several other analysts also recently commented on RELX. Redburn Atlantic initiated coverage on shares of Relx in a report on Wednesday, January 8th. They set a “buy” rating on the stock. StockNews.com cut shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th.
Check Out Our Latest Stock Analysis on RELX
Relx Trading Up 2.5 %
Relx Increases Dividend
The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be given a $0.5586 dividend. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. This is a positive change from Relx’s previous semi-annual dividend of $0.23. Relx’s payout ratio is currently 59.68%.
Institutional Investors Weigh In On Relx
Several hedge funds and other institutional investors have recently added to or reduced their stakes in RELX. CENTRAL TRUST Co grew its holdings in shares of Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after acquiring an additional 529 shares in the last quarter. Versant Capital Management Inc bought a new position in shares of Relx in the fourth quarter valued at $31,000. Transce3nd LLC acquired a new position in Relx during the fourth quarter worth $40,000. Sierra Ocean LLC acquired a new stake in Relx in the fourth quarter valued at $43,000. Finally, Brown Brothers Harriman & Co. grew its position in shares of Relx by 218.5% in the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company’s stock valued at $44,000 after acquiring an additional 662 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
- Five stocks we like better than Relx
- How to Invest in Biotech Stocks
- How to Build the Ultimate Everything ETF Portfolio
- There Are Different Types of Stock To Invest In
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is the Australian Securities Exchange (ASX)
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.